TB-500 / KPV / BPC-157
TB-500 / KPV / BPC-157, 30mg from $160. TB-500, KPV and BPC-157 at 10 mg each. 99%+ HPLC, COA per lot. Research use only.
Select Vial Specification:- ISO/IEC 17025 independent lab tested (HPLC & Mass Spectrometry)
- Scannable QR code on every vial linking directly to lot COA
- Complimentary MBP-H2O reconstitution water included
- Same-day tracked dispatch on orders placed before 2:00 PM EST
Research Description
This is a blend. TB-500, KPV and BPC-157 are combined in a single 30 mg vial, 10 mg of each. All three appear in tissue and inflammation research, but they work through different routes. TB-500 has been studied at actin, a protein that lets cells change shape and move. KPV has been studied at NF-kB, a signalling pathway involved in inflammation. BPC-157 has been studied at growth factor pathways and blood vessel formation. Researchers use blends to compare combined conditions against single compounds.
TB-500 sequesters G-actin monomers, with cytoskeletal remodelling and cell migration toward injury sites measured. Integrin-linked kinase (ILK) signalling is also characterised.
KPV is the C-terminal tripeptide of α-MSH. At nanomolar concentrations, lower NF-κB and MAP-kinase pathway activation is measured in vitro, alongside reduced TNF-α, IL-6 and IL-1β secretion. Cellular uptake runs through the PepT1 transporter.
Storage & Handling Protocol
Store lyophilized vials at −20 °C for long-term stability (up to 24 months) or 2–8 °C for short-term laboratory protocols. Protect from direct light and moisture. Strictly for in-vitro laboratory research use only.
Quality & Lot Specifications
| Compound | TB-500 / KPV / BPC-157 |
| Category | Peptide Blends |
| Lot Number | MBP-6413 → |
| Purity (RP-HPLC) | ≥ 99.0% (Verified) |
| Identity | Confirmed via ESI-MS |
| Endotoxin Screen | < 0.5 EU/mg (LAL Assay) |
| Physical Form | Lyophilized powder (No fillers) |
| Storage Temp | −20 °C Long-Term |
Customer Reviews
No reviews yet — click '+ Write a Review' to share your experience!